ConductScience.org, home

Paper22914404

Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.

Grimm C and 9 others. Obstet Gynecol, 2012. Cited by 108 papers, by iCite.

Cite this record

ConductScience Library. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial. Papers, record 22914404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22914404

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
PubMed
Journal
Obstet Gynecol
PubMed
Year
2012
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
108
iCite
Relative citation ratio, by iCite
2.87
iCite
Revised in PubMed
2022-12-07
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grimm CChristoph
2Polterauer SStephan
3Natter CCamilla
4Rahhal JJasmin
5Hefler LLukas
6Tempfer CBClemens B
7Heinze GGeorg
8Stary GGeorg
9Reinthaller AAlexander
10Speiser PPaul

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoquinolinesMajor topic
Antineoplastic AgentsMajor topic
Uterine Cervical NeoplasmsMajor topic
Uterine Cervical DysplasiaMajor topic
Adult
Female
Humans
Imiquimod
Papillomavirus Infections
Remission Induction
Treatment Outcome
Viral Load
Young Adult

Source PubMed

Download CSV of topics

Trials7

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00941252ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-TrialDerived from the trialYesClinicalTrials.gov
NCT02329171Imiquimod Treatment of CIN LesionsBackgroundClinicalTrials.gov
NCT02669459Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study ProtocolResultsClinicalTrials.gov
NCT02917746Imiquimod Treatment of High-grade CINBackgroundClinicalTrials.gov
NCT03233412Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial LesionsResultsClinicalTrials.gov
NCT04859361Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZBackgroundClinicalTrials.gov
NCT06686043HPV Vaccine, Imiquimod, and Metformin Combination TrialBackgroundClinicalTrials.gov

Download CSV of trials

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.

PMIDTitleJournalYearIn PapersSource
42882092
From Active Compound to Target Epithelium: Local Delivery, Preclinical Model Validity, and Clinical Endpoint Interpretation in Topical Therapy for HPV-Associated Lower Genital Tract Disease-A Narrative Review.
J Clin Med2026https://conductscience.org/library/papers/42882092PubMed
41107612Topical vaginal drug therapy in cervical cancer management: a review of clinical trials and preclinical evidence.Med Oncol2025https://conductscience.org/library/papers/41107612PubMed
40632662Improving imiquimod use in cervical high-grade squamous intraepithelial lesions: A qualitative study.Acta Obstet Gynecol Scand2025https://conductscience.org/library/papers/40632662PubMed
40556801
'ARVs is for HIV and cream is for HPV or precancer:' Women's perceptions and perceived acceptability of self-administered topical therapies for cervical precancer treatment: a qualitative study from Kenya.
Ecancermedicalscience2025https://conductscience.org/library/papers/40556801PubMed
40530116"Prime and pull" vaccination strategy for treatment of cervical pre-cancer: not quite ready for prime time.Transl Cancer Res2025https://conductscience.org/library/papers/40530116PubMed
40362199Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical Dysplasia: A Narrative Review.Int J Mol Sci2025https://conductscience.org/library/papers/40362199PubMed
40282913Evaluation of the Efficacy of Active Hexose Correlated Compound as an Adjuvant in Reducing Recurrence After Condyloma Cauterization.Medicina (Kaunas)2025https://conductscience.org/library/papers/40282913PubMed
40034605Transient bacteraemia secondary to imiquimod use as a treatment for cervical high-grade squamous intraepithelial lesions - A case report.Case Rep Womens Health2025https://conductscience.org/library/papers/40034605PubMed
40005442The Role of Medical Therapies in the Management of Cervical Intraepithelial Neoplasia: A Narrative Review.Medicina (Kaunas)2025https://conductscience.org/library/papers/40005442PubMed
39950806Sexually transmitted human papillomavirus and related sequelae.Clin Microbiol Rev2025https://conductscience.org/library/papers/39950806PubMed
39920276Dendritic cell maturation in cancer.Nat Rev Cancer2025https://conductscience.org/library/papers/39920276PubMed
39065561Imiquimod-Loaded Nanosystem for Treatment Human Papillomavirus-Induced Lesions.Pharmaceutics2024https://conductscience.org/library/papers/39065561PubMed
39021542Men's perceptions and perceived acceptability of their female partner's use of self-administered intravaginal therapies for treatment of cervical precancer in Kenya.Ecancermedicalscience2024https://conductscience.org/library/papers/39021542PubMed
38672691Imiquimod Is Effective in Reducing Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis.Cancers (Basel)2024https://conductscience.org/library/papers/38672691PubMed
38585806Perceived acceptability of self-administered topical therapy for cervical precancer treatment among women undergoing cervical cancer screening in Kenya.medRxiv2024https://conductscience.org/library/papers/38585806PubMed
38556619Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial.BJOG2025https://conductscience.org/library/papers/38556619PubMed
38553612YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells.Apoptosis2024https://conductscience.org/library/papers/38553612PubMed
38532929"There is nothing that can prevent me from supporting her:" men's perspectives on their involvement and support of women's use of topical therapy for cervical precancer treatment in Kenya.Front Oncol2024https://conductscience.org/library/papers/38532929PubMed
38420364Effect of different interventions on the treatment of high-risk human papillomavirus infection: a systematic review and network meta-analysis.Front Med (Lausanne)2024https://conductscience.org/library/papers/38420364PubMed
38254888Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies.Cancers (Basel)2024https://conductscience.org/library/papers/38254888PubMed

See all 66 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
IMIQUIMODCHEMBL1282Results3https://conductscience.org/library/drugs/CHEMBL1282

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22914404

GET https://conductscience.org/api/papers/v1/22914404/cited_by?page=2